Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate

Completed · Phase 4

Conditions studied: Asthma

In brief

This study may last up to 36-38 weeks. Patients will visit the clinic 11 times. A blood sample will be taken at Visit 1 to look at subjects' genes. Breathing tests will be done during the study. Study medicines and procedures will be provided at no cost. Patients will be treated with VENTOLIN (8 wks), ATROVENT (8 wks), then ADVAIR or SEREVENT (16 wks). ADVAIR and SEREVENT are FDA approved for the treatment of asthma in patients 4 years of age and older.

Key facts

Study ID

NCT00102882

Run by

GlaxoSmithKline

People needed

547

Starts

2004-10-01

Expected to finish

2007-01-01

Last updated by the study team

2017-02-03

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of persistent asthma for 3 months.
• Use of short-acting beta-agonist medication like VENTOLIN.

You may not qualify if…

• Hospitalization for asthma 6 months before study.
• Other serious diseases like congestive heart failure, uncontrolled hypertension, TB.
• Current use of inhaled or oral corticosteroids.

Where it is running

• GSK Investigational Site — Little Rock, Arkansas, United States
• GSK Investigational Site — Fresno, California, United States
• GSK Investigational Site — Fullerton, California, United States
• GSK Investigational Site — Huntington Beach, California, United States
• GSK Investigational Site — Inglewood, California, United States
• GSK Investigational Site — Irvine, California, United States
• GSK Investigational Site — Long Beach, California, United States
• GSK Investigational Site — Long Beach, California, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Orange, California, United States
• GSK Investigational Site — Spring Valley, California, United States
• GSK Investigational Site — Stockton, California, United States
• GSK Investigational Site — Colorado Springs, Colorado, United States
• GSK Investigational Site — Denver, Colorado, United States
• GSK Investigational Site — Denver, Colorado, United States
• GSK Investigational Site — Lakewood, Colorado, United States
• GSK Investigational Site — Wheat Ridge, Colorado, United States
• GSK Investigational Site — Waterbury, Connecticut, United States
• GSK Investigational Site — Coral Gables, Florida, United States
• GSK Investigational Site — Jacksonville, Florida, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Orlando, Florida, United States
• GSK Investigational Site — Mobile, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.